Fort Washington Investment Advisors Inc. OH Raises Stock Holdings in The Ensign Group, Inc. $ENSG

Fort Washington Investment Advisors Inc. OH boosted its position in The Ensign Group, Inc. (NASDAQ:ENSG) by 8.4% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 163,131 shares of the company’s stock after purchasing an additional 12,602 shares during the quarter. Fort Washington Investment Advisors Inc. OH owned approximately 0.28% of The Ensign Group worth $28,417,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Legacy Wealth Asset Management LLC grew its position in shares of The Ensign Group by 0.8% in the 4th quarter. Legacy Wealth Asset Management LLC now owns 11,404 shares of the company’s stock worth $1,987,000 after buying an additional 95 shares during the period. SG Americas Securities LLC lifted its position in The Ensign Group by 70.2% during the 4th quarter. SG Americas Securities LLC now owns 38,029 shares of the company’s stock valued at $6,625,000 after acquiring an additional 15,683 shares during the period. Harbor Investment Advisory LLC boosted its stake in The Ensign Group by 125.6% during the fourth quarter. Harbor Investment Advisory LLC now owns 194 shares of the company’s stock worth $34,000 after acquiring an additional 108 shares in the last quarter. Park Avenue Securities LLC boosted its stake in The Ensign Group by 4.7% during the fourth quarter. Park Avenue Securities LLC now owns 12,652 shares of the company’s stock worth $2,204,000 after acquiring an additional 567 shares in the last quarter. Finally, GAMMA Investing LLC grew its holdings in The Ensign Group by 10.3% in the fourth quarter. GAMMA Investing LLC now owns 3,923 shares of the company’s stock worth $683,000 after purchasing an additional 366 shares during the period. Hedge funds and other institutional investors own 96.12% of the company’s stock.

The Ensign Group Stock Down 0.7%

Shares of The Ensign Group stock opened at $200.66 on Friday. The company has a 50-day simple moving average of $199.37 and a two-hundred day simple moving average of $185.08. The stock has a market capitalization of $11.62 billion, a PE ratio of 34.36, a price-to-earnings-growth ratio of 1.98 and a beta of 0.83. The Ensign Group, Inc. has a 52-week low of $118.73 and a 52-week high of $218.00. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.42 and a current ratio of 1.42.

The Ensign Group (NASDAQ:ENSG) last posted its quarterly earnings results on Wednesday, February 4th. The company reported $1.82 EPS for the quarter, beating analysts’ consensus estimates of $1.75 by $0.07. The Ensign Group had a net margin of 6.80% and a return on equity of 16.76%. The firm had revenue of $1.36 billion for the quarter, compared to analysts’ expectations of $1.37 billion. During the same quarter in the prior year, the company posted $1.49 earnings per share. The business’s revenue for the quarter was up 20.2% on a year-over-year basis. The Ensign Group has set its FY 2026 guidance at 7.410-7.610 EPS. On average, analysts anticipate that The Ensign Group, Inc. will post 5.59 EPS for the current fiscal year.

The Ensign Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Thursday, April 30th. Shareholders of record on Tuesday, March 31st will be issued a $0.065 dividend. The ex-dividend date of this dividend is Tuesday, March 31st. This represents a $0.26 dividend on an annualized basis and a dividend yield of 0.1%. The Ensign Group’s dividend payout ratio (DPR) is presently 4.45%.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on ENSG shares. Truist Financial set a $215.00 target price on shares of The Ensign Group and gave the company a “hold” rating in a report on Friday, February 6th. UBS Group set a $230.00 price target on The Ensign Group and gave the stock a “buy” rating in a research note on Friday, February 6th. Wall Street Zen raised The Ensign Group from a “hold” rating to a “buy” rating in a research report on Saturday, February 7th. Zacks Research upgraded The Ensign Group from a “hold” rating to a “strong-buy” rating in a research note on Thursday, February 26th. Finally, Royal Bank Of Canada reissued an “outperform” rating and issued a $222.00 target price (up from $206.00) on shares of The Ensign Group in a report on Monday, February 9th. One equities research analyst has rated the stock with a Strong Buy rating, five have given a Buy rating and one has given a Hold rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Buy” and an average target price of $204.60.

Insiders Place Their Bets

In other news, Director Daren Shaw sold 1,000 shares of the business’s stock in a transaction on Tuesday, February 17th. The stock was sold at an average price of $213.43, for a total value of $213,430.00. Following the completion of the transaction, the director owned 23,726 shares in the company, valued at $5,063,840.18. The trade was a 4.04% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director John O. Agwunobi sold 146 shares of the company’s stock in a transaction on Wednesday, January 21st. The shares were sold at an average price of $178.31, for a total value of $26,033.26. Following the transaction, the director directly owned 9,087 shares in the company, valued at approximately $1,620,302.97. The trade was a 1.58% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders have sold 17,073 shares of company stock worth $3,333,390. 3.90% of the stock is owned by corporate insiders.

About The Ensign Group

The Ensign Group, Inc is a diversified provider of post-acute healthcare services in the United States, operating a network of skilled nursing, assisted living, independent living, home health and hospice care centers. The company’s model emphasizes integrated care by employing multidisciplinary teams—including nursing staff, therapists and physicians—to deliver personalized rehabilitation and long-term care services for seniors and other patients recovering from injury, illness or surgery.

Through its owned and managed centers, The Ensign Group offers a broad spectrum of rehabilitation services such as physical, occupational and speech therapy.